Contact us

Solia S is the only LBBAP lead FDA approved following a prospective IDE clinical trial.1

Used in more than 80,000 patients worldwide and backed by more than 30 clinical studies to date,1 BIOTRONIK’s Solia S & Selectra 3D are the first and only FDA approved stylet-driven lead and dedicated delivery catheter combination for LBBAP.1

Implant with Confidence

  • Solia S is the only lead backed by a prospective IDE trial, demonstrating a high implant success rate of 95.7%.3
  • Low lead complication rate and low, stable threshold at 12 month follow up.4

Drive Efficiency

  • 17% shorter lead implantation time for stylet-driven leads vs lumenless leads.6
  • Less hassle with continuous electrical measurements7 and no need for special, costly tools.

Solia’s stylet provides enhanced support and better torquability to facilitate deep septal deployment.7

Stylet-driven leads like Solia S require shorter implant and fluoroscopy times compared with lumenless lead designs.8

Selectra 3D is the only catheter indicated to facilitate lead implantation in the left bundle area.

Selectra 3D offers a broad range of optimally designed catheters delivering excellent handling.2,5

  • Data on file. As of July 2024.
  • BIOTRONIK Solia S, Selectra 3D technical manuals. Abbott CPS Locator 3D manual; Boston Scientific Ingevity+, SSPC Catheter manuals.
  • Liu, et al. Left bundle branch area pacing using a stylet-driven, retractable-helix lead: Short-term results from a prospective multicenter IDE trial (the BIO-CONDUCT study). Heart Rhythm. 2024 May 19:S1547-5271(24)02547-5. Epub ahead of print.
  • De Pooter, et al. Initial experience of left bundle branch area pacing using stylet-driven pacing leads: A multicenter study. J Cardiovasc Electrophysiol. 2022; 33(7):1540-1549.
  • De Pooter, et al. Utility of a guiding catheter for conduction system pacing: an early multicentre experience. Heart Rhythm O2. 2024;5(1):8-16.
  • Sritharan, et al. Procedural outcome and follow-up of stylet-driven leads compared with lumenless leads for left bundle branch area pacing. Europace. 2023 Oct 5;25(10)
  • Burri H, Jastrzebski M, Cano Ó, et al. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace. 2023; 25(4): 1208-1236.
  • Cano, et al. Acute performance of stylet driven leads for left bundle branch area pacing: A comparison with lumenless leads. Heart Rhythm O2. 2023;4:765-776.

* 45 cm length not indicated for LBBAP

Contact us